Shangchun Bio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 3

Shangchun Bio General Information

Description

Manufacturer of upstream raw materials designed for cell and gene therapy development. The company utilizes molecular research, laboratory testing, technical consulting, material synthesis, and quality control, providing biopharmaceutical companies with specialized raw materials for therapy development and technical support for production.

Contact Information

Website
www.shangchunbiotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9th Floor, Building A, R&D Building
  • Number 666, Shendun Fourth Road, East Lake High-tech Development Zone
  • Wuhan, Hubei 430206
  • China
+86 027
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Discovery Tools (Healthcare)
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 9th Floor, Building A, R&D Building
  • Number 666, Shendun Fourth Road, East Lake High-tech Development Zone
  • Wuhan, Hubei 430206
  • China
+86 027

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Shangchun Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 03-Aug-2026 Completed Generating Revenue
2. Early Stage VC 16-Jul-2026 Completed Generating Revenue
1. Early Stage VC 21-Apr-2026 Completed Generating Revenue
To view Shangchun Bio’s complete valuation and funding history, request access »

Shangchun Bio Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

Shangchun Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026228045-A1 Nanobody specifically binding to aav2, and use thereof Pending 30-Apr-2025
WO-2026228008-A1 Nanobody that specifically binds to aav9 and application thereof Pending 30-Apr-2025

Shangchun Bio Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wuhan Optics Valley Elite Investment Management Venture Capital Minority
Dongke Chuangxing Venture Capital Minority
Wuhan Innovation Investment Group Venture Capital Minority
To view Shangchun Bio’s complete investors history, request access »

Ready to get started?

Request a free trial

Shangchun Bio FAQs

  • When was Shangchun Bio founded?

    Shangchun Bio was founded in 2021.

  • Where is Shangchun Bio headquartered?

    Shangchun Bio is headquartered in Wuhan, China.

  • What industry is Shangchun Bio in?

    Shangchun Bio’s primary industry is Biotechnology.

  • Is Shangchun Bio a private or public company?

    Shangchun Bio is a Private company.

  • What is Shangchun Bio’s current revenue?

    The current revenue for Shangchun Bio is .

  • Who are Shangchun Bio’s investors?

    Wuhan Optics Valley Elite Investment Management, Dongke Chuangxing, and Wuhan Innovation Investment Group have invested in Shangchun Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process